Clinical Trials in Zenica, Bosnia and Herzegovina
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)
Non-squamous Non-small Cell Lung Cancer
mAbxience Research S.L.726 enrolled151 locationsNCT06687369
Recruiting
Phase 1
A Study of Aumolertinib in European Participants With Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.20 enrolled6 locationsNCT07130916